Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, and if it is accurately predicted ...
Safety and biomarker assessment of ST316, a novel peptide antagonist of ß-catenin, in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...
Reflecting on the developments of 2024, this year has been transformative for the entire educational landscape. We’ve witnessed how the thoughtful integration of artificial intelligence can elevate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback